Cabozantinib did not increase survival of heavily treated patients with mCRPC, compared with prednisone.
The surgery reduced the risk of death from any cause by 37%, meta-analysis shows.
A meta-analysis has determined that metformin is still the first-line treatment for diabetes.
The Mediterranean Diet may reduce patients risks of breast cancer, cardiovascular disease, and diabetes.
Over 33 months, the 25-hydroxyvitamin D level of ergocalciferol recipients increased significantly from 15.14 to 37.32 ng/mL.
Research emphasizes the need for nationwide refinements in the prostate cancer screening process.
After visiting an endemic area, a New York City woman is the first reported case of female-to-male Zika virus transmission.
In a small study, some men whose cancer progressed while on enzalutamide had a profound PSA response to pembrolizumab.
Notably, gliclazide did not appear superior to other sulfonylureas.
Findings in patients treated for T1a renal cell carcinoma followed with X-ray surveillance.
CDC statistics for 2013 to 2014 show troubling increase in resistant strains.
The risk of peripheral arterial disease was 34% lower for end-stage renal disease patients who underwent the procedure.
Study implicates higher consumption of advanced glycation end products through dietary fat.
Adjusted odds ratio of prostate cancer significantly higher for MRI score than PSA.
Future studies are needed to assess potential benefits of hypertension screening for daytime nappers.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)